Baylor College Of Medicine

This early-phase study tests a new treatment for people with certain blood cancers (like acute myeloid leukemia) that have come back or not responded to standard care. Researchers take a patient's own immune cells, modify them in the lab to recognize and attack cancer cells carry…

This early-phase trial tests a new treatment for children with a rare and aggressive brain tumor called atypical teratoid rhabdoid tumor (ATRT) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified in the lab to bette…